The Effect of Remdesivir and Convalescent Plasma in Severe COVID-19 in Pregnancy
dc.contributor.author | Elantably, Ahmed | |
dc.contributor.author | Elantably, Dina | |
dc.contributor.author | Ashraf, Usman | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2022-02-25T19:59:01Z | |
dc.date.available | 2022-02-25T19:59:01Z | |
dc.date.issued | 2021-05-31 | |
dc.description.abstract | There are limited data regarding treatment options for pregnant women with severe coronavirus disease 2019 (COVID-19). However, the use of convalescent plasma therapy and remdesivir in was reported to be successful in the management of a critically ill obstetric patient with novel coronavirus 2019 infection | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Elantably, A., Elantably, D., Ashraf, U. (2021). The Effect of Remdesivir and Convalescent Plasma in Severe COVID-19 in Pregnancy. Clinical Medical Reviews and Case Reports, 8(5), 349. https://doi.org/10.23937/2378-3656/1410349 | en_US |
dc.identifier.issn | 2378-3656 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/27983 | |
dc.language.iso | en | en_US |
dc.publisher | ClinMed International Library | en_US |
dc.relation.isversionof | 10.23937/2378-3656/1410349 | en_US |
dc.relation.journal | Clinical Medical Reviews and Case Reports | en_US |
dc.rights | Attribution 4.0 United States | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | Publisher | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Remdesivir | en_US |
dc.subject | pregnancy | en_US |
dc.title | The Effect of Remdesivir and Convalescent Plasma in Severe COVID-19 in Pregnancy | en_US |
dc.type | Article | en_US |